Your browser doesn't support javascript.
loading
Adaptive immunity and vaccination - iron in the spotlight.
Preston, Alexandra E; Drakesmith, Hal; Frost, Joe N.
Afiliação
  • Preston AE; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Drakesmith H; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Frost JN; Haematology Theme, Oxford Biomedical Research Centre, Oxford, UK.
Immunother Adv ; 1(1): ltab007, 2021 Jan.
Article em En | MEDLINE | ID: mdl-35919735
Vaccination programmes are critically important to suppress the burden of infectious diseases, saving countless lives globally, as emphasised by the current COVID-19 pandemic. Effective adaptive immune responses are complex processes subject to multiple influences. Recent genetic, pre-clinical, and clinical studies have converged to show that availability of iron is a key factor regulating the development of T and B cell responses to infection and immunisation. Lymphocytes obtain iron from circulating transferrin. The amount of iron bound to transferrin is dependent on dietary iron availability and is decreased during inflammation via upregulation of the iron-regulatory hormone, hepcidin. As iron deficiency and chronic inflammatory states are both globally prevalent health problems, the potential impact of low iron availability on immune responses is significant. We describe the evidence supporting the importance of iron in immunity, highlight important unknowns, and discuss how therapeutic interventions to modulate iron availability might be implementable in the context of vaccination and infectious disease.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Immunother Adv Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Immunother Adv Ano de publicação: 2021 Tipo de documento: Article